No headlines found.
Mannatech Reports Financial Results for Third Quarter 2025
Globe Newswire (Wed, 12-Nov 4:02 PM ET)
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
Mannatech trades on the NASDAQ stock market under the symbol MTEX.
As of December 19, 2025, MTEX stock price declined to $8.00 with 5,805 million shares trading.
MTEX has a beta of 0.52, meaning it tends to be less sensitive to market movements. MTEX has a correlation of 0.02 to the broad based SPY ETF.
MTEX has a market cap of $15.21 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, MTEX traded as high as $21.50 and as low as $6.75.
The top ETF exchange traded funds that MTEX belongs to (by Net Assets): VTI, VXF, BSVO, DFAT, DCOR.
MTEX has underperformed the market in the last year with a price return of -32.7% while the SPY ETF gained +17.4%. MTEX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -4.8% and -14.0%, respectively, while the SPY returned +3.4% and -0.5%, respectively.
MTEX support price is $7.81 and resistance is $8.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MTEX shares will trade within this expected range on the day.
